menu
    • menu

    Company profile for LENZ Therapeutics

    NEW Drugs in Dev: 3
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products. LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 1...
    LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products. LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LENZ TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lenz-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lenztx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LENZ Pharma And Sarah Jessica Parker Launch 'Make It Vizzable'
    LENZ Pharma And Sarah Jessica Parker Launch 'Make It Vizzable'

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218622/0/en/LENZ-Therapeutics-and-Sarah-Jessica-Parker-announce-the-launch-of-Make-it-VIZZable-the-VIZZ-consumer-campaign.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    LENZ Therapeutics Reports Q4 2025 Results and Corporate Updates
    LENZ Therapeutics Reports Q4 2025 Results and Corporate Updates

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214959/0/en/LENZ-Therapeutics-Reports-Fourth-Quarter-2025-Preliminary-Unaudited-Financial-Results-and-Recent-Corporate-Updates.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    LENZ, Lunatus Announce Exclusive VIZZ Mideast Partnership
    LENZ, Lunatus Announce Exclusive VIZZ Mideast Partnership

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212729/0/en/LENZ-Therapeutics-and-Lunatus-Announce-Exclusive-Commercialization-Partnership-for-VIZZ-in-the-Middle-East.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    LENZ Therapeutics Submits LNZ100 NDA to Korea's FDA
    LENZ Therapeutics Submits LNZ100 NDA to Korea's FDA

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196996/0/en/LENZ-Therapeutics-Announces-MFDS-Submission-of-New-Drug-Application-for-LNZ100-VIZZ-in-South-Korea-for-the-Treatment-of-Presbyopia.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    LENZ Therapeutics To Present At Upcoming Investor Conferences
    LENZ Therapeutics To Present At Upcoming Investor Conferences

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194718/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    LENZ Therapeutics Reveals Q3 2025 Financials & Highlights
    LENZ Therapeutics Reveals Q3 2025 Financials & Highlights

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181420/0/en/LENZ-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search